tirzepatide for nash in Consistent improvements liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with The percentage of participants who – The percentage of participants who

10.1126/sciadv.adn6068 134 SrivastavaS

Slower injection technique and subcutaneous placement in areas with less blood flow may delay peak drug absorption and symptom onset by several hours

Actual price will depend on product, subscription, and length of commitment

They love this idea because it: Reduces polypharmacy Reduces cost Reduces adverse drug events Improves life quality for those with apnea and diabetes They conclude, We strongly advocate for increased and early use of GLP-1 agonists in obstructive sleep apnea patients with co-occurring diabetes and other cardiometabolic conditions common in obstructive sleep apnea. They start with defining obstructive sleep apnea